Detalhe da pesquisa
1.
Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses.
Cancer Cell
; 40(7): 738-753.e5, 2022 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35679859
2.
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies.
Blood Cancer Discov
; 2(6): 568-576, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778797
3.
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer.
Nat Med
; 27(7): 1280-1289, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017137
4.
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
Res Sq
; 2021 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564756